Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids. 1985

P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann

A series of (mercaptoaroyl)amino acids and related compounds was synthesized and tested for ability to inhibit angiotensin converting enzyme (ACE). The most active compound was N-(3-chloro-2-mercaptobenzoyl)-N-cyclopentylglycine, having an in vitro I50 = 0.28 microM. Substitution of the aromatic 3-position by small polar groups enhanced ACE inhibitory activity, whereas bulky groups diminished it. Alteration of the beta relationship between the mercaptan and amide carbonyl or masking of the thiol by acylation reduced activity. Replacement of the thiol by nitro, hydroxy, or carboxy gave compounds lacking ACE inhibitory activity.

UI MeSH Term Description Entries
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013440 Sulfides Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties. Sulfide,Thioether,Thioethers,Sulfur Ethers,Ethers, Sulfur
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
December 1977, Biochemistry,
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
April 1990, American journal of hypertension,
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
January 1995, Journal de pharmacie de Belgique,
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
September 1987, The Medical clinics of North America,
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
May 1992, AACN clinical issues in critical care nursing,
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
July 2006, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
September 2011, Journal of clinical hypertension (Greenwich, Conn.),
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
November 1980, American family physician,
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
February 1988, British medical journal (Clinical research ed.),
P R Menard, and J T Suh, and H Jones, and B Loev, and E S Neiss, and J Wilde, and A Schwab, and W S Mann
December 1989, American heart journal,
Copied contents to your clipboard!